JCR Pharmaceuticals Co., Ltd. (TYO:4552)
Japan · Delayed Price · Currency is JPY 601.00
+13.00 (2.21%)
Mar 27, 2026, 3:30 PM JST
JCR Pharmaceuticals Employees
JCR Pharmaceuticals had 987 employees as of March 31, 2025. The number of employees increased by 53 or 5.67% compared to the previous year.
Employees
987
Change (1Y)
53
Growth (1Y)
5.67%
Revenue / Employee
38.04M JPY
Profits / Employee
-2.47M JPY
Market Cap
73.31B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 987 | 53 | 5.67% |
| Mar 31, 2024 | 934 | 55 | 6.26% |
| Mar 31, 2023 | 879 | 63 | 7.72% |
| Mar 31, 2022 | 816 | 84 | 11.48% |
| Mar 31, 2021 | 732 | 65 | 9.75% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Otsuka Holdings | 37,758 |
| Daiichi Sankyo Company | 19,765 |
| Astellas Pharma | 13,643 |
| Chugai Pharmaceutical | 7,872 |
| Kyowa Kirin | 5,669 |
| Ono Pharmaceutical | 4,287 |
| Santen Pharmaceutical | 3,849 |
| Perseus Proteomics | 32 |
JCR Pharmaceuticals News
- 7 weeks ago - JCR Pharmaceuticals' Research Presentations at WORLDSymposium™ 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders - Business Wire
- 2 months ago - JCR Pharmaceuticals to Present at the 22nd Annual WORLDSymposium™ 2026 - Business Wire
- 2 months ago - JCR Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 3 months ago - Italfarmaco and JCR Pharmaceuticals Announce Commercialisation Agreement for Givinostat in Japan and Strategic Collaboration in Rare Disease - Business Wire
- 6 months ago - JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to Central Nervous System and Muscle with Novel Capsid Engineering Platform Technology - Business Wire
- 6 months ago - JCR Pharmaceuticals Announces Licensing Agreement with Menagen to Commercialize Agalsidase Beta BS I.V. Infusion [JCR] Across Nine MENAT Markets - Business Wire
- 6 months ago - JCR Pharmaceuticals to Present at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress - Business Wire
- 6 months ago - JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program - Business Wire